The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ENLIGHten-01: A phase 1 study of fluorescein-specific (FITC-E2)-CAR T cells in combination with folate-fluorescein (UB-TT170) for osteosarcoma.
 
Catherine Michelle Albert
No Relationships to Disclose
 
Navin R. Pinto
Patents, Royalties, Other Intellectual Property - I hold a patent 20210346431 that has been licensed to Umoja Biotherapeutics and may result in royalty payments. No payments have been received to date.
(OPTIONAL) Uncompensated Relationships - Y-mAbs Therapeutics
 
Mallory Taylor
No Relationships to Disclose
 
Ashley Wilson
No Relationships to Disclose
 
Stephanie Rawlings-Rhea
No Relationships to Disclose
 
Wenjun Huang
No Relationships to Disclose
 
Kristy Seidel
No Relationships to Disclose
 
Prabha Narayanaswamy,
No Relationships to Disclose
 
Stephanie Mgebroff
No Relationships to Disclose
 
Christopher Brown
No Relationships to Disclose
 
Jacob Garcia
Employment - Umoja Biopharma
 
Jeffrey Teoh
Employment - Umoja Biopharma
 
Rebecca Alice Gardner
Honoraria - crispr therapeutics; Novartis; SOBI; SOBI
Research Funding - 2seventy bio
Patents, Royalties, Other Intellectual Property - IP and royalties are received from BMS related to CAR technology patents
Travel, Accommodations, Expenses - Novartis
 
Rimas Orentas
Stock and Other Ownership Interests - Umoja Biopharma
Consulting or Advisory Role - Umoja Biopharma
 
Michael C. Jensen
Leadership - Bristol-Myers Squibb; Umoja Biopharma
Stock and Other Ownership Interests - Bristol-Myers Squibb; Umoja Biopharma
Patents, Royalties, Other Intellectual Property - Bristol Myers Squibb; Umoja Biopharma
 
Julie R. Park
Patents, Royalties, Other Intellectual Property - Umoja Biopharma